Statistical analyses revealed a significant positive correlation between IGFBP-2 and IL-6 and a negative correlation between IGFBP-2 and IGFBP-3, suggesting that inflammation is an important modulator of the IGF-IGFBP system with an overall reduction in IGF bioactivity in CF [68]. This evidence concerns the gene IL6 and cystic fibrosis.